Polymer Capital Management HK LTD Acquires New Stake in SPDR S&P Biotech ETF $XBI

Polymer Capital Management HK LTD bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 105,300 shares of the exchange traded fund’s stock, valued at approximately $16,664,000. SPDR S&P Biotech ETF comprises approximately 0.8% of Polymer Capital Management HK LTD’s investment portfolio, making the stock its 15th biggest position.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Wealth Management Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $547,000. Keystone Investors PTE Ltd. acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $12,022,000. Lalia Capital LLC purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth approximately $12,193,000. Jessup Wealth Management Inc purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth approximately $1,053,000. Finally, Rockefeller Capital Management L.P. raised its holdings in SPDR S&P Biotech ETF by 44.4% in the 4th quarter. Rockefeller Capital Management L.P. now owns 236,057 shares of the exchange traded fund’s stock valued at $28,782,000 after acquiring an additional 72,636 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $165.73 on Monday. SPDR S&P Biotech ETF has a fifty-two week low of $88.60 and a fifty-two week high of $169.68. The firm has a market cap of $10.82 billion, a PE ratio of 11.47 and a beta of 0.83. The business’s fifty day moving average is $153.99 and its two-hundred day moving average is $137.76.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.